Shanghai Bio-heart Biological Technology Co Ltd
HKEX:2185
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shanghai Bio-heart Biological Technology Co Ltd
HKEX:2185
|
CN |
|
Alliance Nickel Ltd
OTC:AXNLF
|
AU |
Shanghai Bio-heart Biological Technology Co Ltd
Shanghai Bio-Heart Biological Technology Co., Ltd. engages in the development of cardiovascular devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-12-23. The firm's main businesses are the development and production of interventional cardiovascular devices. The firm's main products include fully bioresorbable scaffolds (BRS) and renal denervation (RDN). The firm's products are mainly used to meet medical needs for the treatment of coronary, peripheral artery disease and hypertension.
Shanghai Bio-Heart Biological Technology Co., Ltd. engages in the development of cardiovascular devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-12-23. The firm's main businesses are the development and production of interventional cardiovascular devices. The firm's main products include fully bioresorbable scaffolds (BRS) and renal denervation (RDN). The firm's products are mainly used to meet medical needs for the treatment of coronary, peripheral artery disease and hypertension.